NasdaqGS:MBLY
NasdaqGS:MBLYAuto Components

Mobileye Global (NasdaqGS:MBLY) Welcomes Patrick Bombach to Board as Stock Dips 13%

Mobileye Global (NasdaqGS:MBLY) recently welcomed Patrick Bombach to its Board of Directors, an event that adds to the evolving governance of the company. Despite this leadership change, Mobileye Global's stock price fell 13% over the past month, coinciding with broader market turbulence. U.S. tariffs impacting tech and consumer sectors and significant market drops likely pressured the company's performance. The Dow, S&P 500, and Nasdaq all experienced sharp declines, with tech stocks, in...
NasdaqCM:BTDR
NasdaqCM:BTDRSoftware

Bitdeer Technologies Group (NasdaqCM:BTDR) Sees 14% Dip After US$532 Million Net Loss Announced

Bitdeer Technologies Group (NasdaqCM:BTDR) announced significant developments last week, including Q4 2024 results revealing a substantial net loss of USD 532 million, a stark contrast from the previous year, potentially influencing its 13.59% share price decline. Additionally, the company's announcement of a USD 20 million share repurchase program seems to have offered limited immediate reassurance to investors amidst the broader market downturn. The financial report reflected declining...
NasdaqGM:IVVD
NasdaqGM:IVVDBiotechs

Invivyd (NasdaqGM:IVVD) Jumps 163% After Promising Phase 1/2 Trial Results For COVID-19 Antibody

Invivyd (NasdaqGM:IVVD) has seen its share price surge by an impressive 163% over the past month, driven primarily by the positive data released from its Phase 1/2 clinical trial of VYD2311, a novel monoclonal antibody candidate against COVID-19. The clinical trial results highlighted improved efficacy and a favorable safety profile, sparking investor enthusiasm amid market conditions characterized by significant volatility due to newly imposed U.S. tariffs. While major indices like the Dow...
NasdaqCM:SRTS
NasdaqCM:SRTSMedical Equipment

Sensus Healthcare (NasdaqCM:SRTS) Shares Dip 14% After Q4 Earnings Show US$3 Million Net Income Drop

Sensus Healthcare (NasdaqCM:SRTS) recently disclosed fourth-quarter 2024 earnings, revealing a slight rise in sales to USD 13.07 million compared to the previous year, despite a notable decrease in net income from USD 4.21 million to USD 1.55 million. This earnings announcement, coupled with expected lower sales in Q1 2025 relative to Q1 2024, presents a cautious outlook. Over the past week, the company's shares fell 14.07%, potentially influenced by broader market pressures as the Dow Jones...
NYSE:TDW
NYSE:TDWEnergy Services

Tidewater (NYSE:TDW) Stock Slides 19% Following Decline In Q4 2024 Net Income To US$37 Million

Tidewater (NYSE:TDW) faced a challenging week, with its stock price dropping 18.8%. This decline coincided with the company's recent earnings announcement, where it reported a decline in Q4 2024 net income to $36.91 million despite revenue growth. Tidewater's cautious earnings guidance for 2025, projecting revenues between $1.32 billion and $1.38 billion, may have fueled investor apprehension during the period. The strategic shift towards value-accretive acquisitions and increased share...
NasdaqGS:CARG
NasdaqGS:CARGInteractive Media and Services

High Growth Tech Stocks to Watch in US March 2025

Over the last 7 days, the United States market has experienced a 2.5% drop, yet it remains up by 13% over the past year with earnings forecasted to grow by 14% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for innovation and scalability while navigating current market fluctuations effectively.
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Discover Gilead Sciences And 2 More Stocks That May Be Priced Below Intrinsic Estimates

As the U.S. market grapples with the impact of newly imposed tariffs and a broad-based sell-off, investors are keenly assessing opportunities that may arise from these turbulent conditions. In such an environment, identifying stocks that appear to be undervalued based on intrinsic estimates can provide potential avenues for investment, as they might offer resilience against broader economic challenges.
NasdaqGM:GUTS
NasdaqGM:GUTSMedical Equipment

Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks

As the U.S. stock market grapples with the impact of new tariffs and economic uncertainties, investors are increasingly looking for opportunities beyond well-known names. Penny stocks, a term that might seem outdated, still hold relevance as they often represent smaller or newer companies with potential for growth at lower price points. In this article, we explore three intriguing penny stocks that stand out for their financial strength and offer promising opportunities for those seeking...
NasdaqGS:TCBX
NasdaqGS:TCBXBanks

Discovering 3 Undiscovered Gems in the US Market

Over the last 7 days, the United States market has experienced a 2.5% drop, yet it remains up by 13% over the past year with earnings projected to grow by 14% annually in the coming years. In this dynamic environment, identifying stocks that have strong fundamentals and potential for growth can uncover opportunities that might not yet be widely recognized.
NYSE:NTB
NYSE:NTBBanks

3 Dividend Stocks Yielding Up To 6.1%

As the U.S. stock markets grapple with the impact of newly imposed tariffs and economic uncertainties, investors are increasingly seeking stability in dividend stocks. In such volatile times, a good dividend stock can provide a reliable income stream while potentially offering some insulation from market fluctuations.